Brief: China Nt Pharma Group Company Says Trading In Shares Was Halted With Effect From Wednesday, 20 April
20/04/2022 14:47
April 20 (Reuters) - China NT Pharma Group Company Ltd
1011.HK :
* TRADING IN SHARES WAS HALTED WITH EFFECT FROM WEDNESDAY,
20
APRIL
* CURRENTLY IN NEGOTIATION WITH INDEPENDENT THIRD PARTY(IES)
* NEGOTIATION ABOUT POTENTIAL ACQUISITION OF
COMMERCIALISATION
RIGHT OF CERTAIN MONOCLONAL ANTIBODY PRODUCTS, AMONG OTHERS
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY